금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Stocks Rise Pre-Bell as Traders Await Fed Policy Decision, Inflation Report, Big Tech Earnings
The benchmark US stock measures pointed higher before the opening bell Monday as traders gear up for...
Stock market today: Dow, S&P 500, Nasdaq futures rise ahead of busy week of earnings, Fed rate decision
Investors braced for a full earnings docket and the Federal Reserve's next policy decision this week...
British Pound: Stronger PMIs lean hawkish for BoE – Danske Bank
Danske Research Team notes UK flash PMIs strengthened in October, with the composite rising to 53.1 ...
Cleveland-Cliffs Stock Gets a JD Vance Boost
Vice President J.D. Vance visited Cleveland-Cliffs’ Middletown Works in Middletown, Ohio, on Friday, touting America’s manufacturing renaissance. Shares of the steel maker were up 4.8% in late trad ...
Parsons upgraded at Baird as growth seen accelerating in this year's H2
Is Microsoft a Screaming Buy Under $500 Per Share?
Microsoft has rallied back from the plunges it took earlier this year, but can it go higher?
3 Reasons to Avoid OII and 1 Stock to Buy Instead
Oceaneering currently trades at $51.56 and has been a dream stock for shareholders. It’s returned 333% since August 2021, blowing past the S&P 500’s 71.9% gain. The company has also beaten the index o ...
Rocket Lab Stock's Twelve-Month Gain Hides A Long Slide From Its High
Rocket Lab's flight rate moved one way over the past year; its share price moved both ways.
Jim Cramer sends strong verdict on where the market is headed
Jim Cramer went on record about where stocks are headed.
O-I Glass surges as Citi upgrades to Buy after YTD plunge
2 Reasons to Watch PFE and 1 to Stay Cautious
Pfizer has been treading water for the past six months, recording a small return of 2.6% while holding steady at $27.76. The stock also fell short of the S&P 500’s 12.7% gain during that period.
3 Reasons to Sell MED and 1 Stock to Buy Instead
Medifast trades at $11.62 per share and has stayed right on track with the overall market, gaining 9.6% over the last six months. At the same time, the S&P 500 has returned 12.7%.
3 Reasons EPC is Risky and 1 Stock to Buy Instead
Edgewell Personal Care has had an impressive run over the past six months as its shares have beaten the S&P 500 by 10.6%. The stock now trades at $27.57, marking a 23.3% gain. This performance may hav ...
UBS Revamps S&P 500 Price Target For Rest of 2026
UBS Bets on More S&P 500 Gains With Fresh 8,100 Year-End Target
The Treasury, the Fed and the threat to your money
Also in Weekend Reads: The Gen Z online sports-betting trend, what’s next for Apple as Tim Cook exits, and a bullish take on Nvidia heading into earnings.